Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
Date:3/7/2013

ble non-small cell lung cancer. OGX-427 is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development. More information is available at www.OncoGenex.com.

OncoGenex' Forward Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design, statements regarding the potential benefits and potential development of our product candidates and statements regarding our expected financial results and expected cash requirements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product, the risk that our cash resources are insufficient to fund our planned activities for the time period expected and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or t
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
2. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
3. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
9. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
10. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
11. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... mayo de 2015 Dipexium Pharmaceuticals, ... farmacéutica de fase tardía centrada en el ... 0.8%), y colaboradores de investigación clínica, han ... el diseño innovador de los ensayos pivotales ... evalúan Locilex®, su nuevo péptido de antibiótico ...
(Date:5/22/2015)... , May 22, 2015  Effective staffing ... pharmaceutical brand recognition and success. ... a study to provide pharmaceutical and biotech marketing ... (FTEs and budget) that are being channeled into ... biotech marketing managers can utilize this report to ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2
... 18, 2011 Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, ... evaluating the use of Nexavar® (sorafenib) tablets will be presented ... the American Society of Clinical Oncology (ASCO), June 3-7, in ... researching the potential utility of sorafenib, and the number of ...
... Laser ( www.XTRACLaser.com ) treatments, psoriasis patients can say ... skin they have been covering up all winter. Developed ... ), an innovator of medical devices, the XTRAC laser ... from this embarrassing and socially isolating disease. Broad coverage ...
Cached Medicine Technology:Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 2Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 3Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 4Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 5Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 6Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting 7XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 2XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 3XTRAC Laser Treatment Offers Summer Time Relief to Psoriasis Sufferers Covered by Major Insurers 4
(Date:5/25/2015)... Tunstall Americas announces major investment in new technology and ... its Medical Answering Service customers. Through a combination ... now provides a seamless transition between a health care ... superior patient satisfaction. , Tunstall is pleased ... in expanded facilities and the latest telecommunication software and ...
(Date:5/24/2015)... 24, 2015 Women's Excellence in ... loss. Although it is unclear about the etiology of ... factors such as metabolism, nutritional deficiencies, thyroid abnormalities and ... a comprehensive approach to evaluating the metabolic, nutritional and ... can help patients find a cause for their problem. ...
(Date:5/24/2015)... York (PRWEB) May 24, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its next ... of the multidistrict litigation. According to court documents ... of Illinois, the Conference will be convened on ... Testosterone Replacement Therapy Product Liability Litigation - MDL ...
(Date:5/24/2015)... Santa Rosa, CA (PRWEB) May 24, 2015 ... gives a clear indicator that the single best option ... This study reveals that fitness level was the single ... researchers accounted for variables such as diabetes and family ... the significance of maintaining lifelong heart and lung fitness. ...
(Date:5/23/2015)... New York, NY (PRWEB) May 23, 2015 ... (CareFirst) announced that, “the company has been the ... discovered as a part of the company’s ongoing Information ... cyberattacks on health insurers.” , The most notable ... this year when Anthem Inc., the nation’s second largest ...
Breaking Medicine News(10 mins):Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... NEW YORK, Aug. 14 MS -- A ... AstraZeneca, found that while most patients with asthma understand the ... , , "This finding demonstrates a ... the necessary steps people should take to achieve better control," ...
... ... present a technology and admissions educational session for THCA members , ... Atlanta, GA (PRWEB) August 14, 2009 ... providers, announced today that it will present a session at the Tennessee Health Care ...
... San Mateo ... risks inherent in such situations , ... San Mateo, CA (Lexis Nexis) August 14, 2009 -- The tragic accident that occurred ... killed when a small aircraft collided in midair with a helicopter, served as a graphic ...
... , , , ... Commission approved a contribution of up to $81.4 million to the Healthy ... infants and children at risk of losing coverage due to the state,s ... today, will be used to cover children ages 0-5 through June 2010. ...
... John Abdo Brings ... , ... August 13, 2009 -- Author John Abdo, former Olympic Coach and Award-Winning Fitness Hall of ... of research and experience, Abdo introduces his authoritative sexual health book ., , , ...
... , , JACKSON, Miss., ... Mississippi Medicaid benefits for speech therapy services, The Mississippi School Boards ... Medicaid on the new Medicaid claiming policy for the coming school ... services provided by school providers, which are in fact still claimable. ...
Cached Medicine News:Health News:Keeping Asthma Under Control 2Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 2Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 3Health News:Midair Collision over Hudson Provides Tragic Reminder that Airplanes and Helicopters Don't Mix Well, According to Aviation Law Expert 2Health News:First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Program's Viability 2Health News:Definitive Sexual Health Book Released 2Health News:Definitive Sexual Health Book Released 3Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 2Health News:Mississippi School Boards Association and Accelify Attain Clarity on New Medicaid Claiming Policy for Coming School Year 3
The lower body blanket is utilized during surgical procedures covering the head, neck, arms and upper torso of your patient....
The Thermal pads were designed to simulate water immersion, the most effective method of transferring energy non-invasively....
This blanket is ideal for warming the large child or small adult during upper body surgery....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: